Cardiac Allograft Remodeling and Effects of Sirolimus
Public ClinicalTrials.gov record NCT01889992. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cardiac Allograft Remodeling and Effects of Sirolimus on Its Progression
Study identification
- NCT ID
- NCT01889992
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- University of Nebraska
- Other
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Cardiac Allograft Remodeling Other
- Cardiac Biopsy C4D stain Procedure
- Cardiac MRI Radiation
- Cardiopulmonary Exercise Test (CPET) Other
- Coronary angiography with IVUS Procedure
- Genetic Mechanism of M-TOR Genetic
- M-TOR Immunosuppression Drug
Other · Procedure · Radiation + 2 more
Eligibility (public fields only)
- Age range
- 19 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2013
- Primary completion
- Sep 26, 2018
- Completion
- Sep 26, 2018
- Last update posted
- Aug 29, 2023
2013 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01889992, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2023 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01889992 live on ClinicalTrials.gov.